A detailed history of Mattson Financial Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mattson Financial Services, LLC holds 22 shares of BMY stock, worth $1,138. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22
Holding current value
$1,138
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 30, 2024

BUY
$40.25 - $52.99 $885 - $1,165
22 New
22 $914,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $110B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mattson Financial Services, LLC Portfolio

Follow Mattson Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mattson Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mattson Financial Services, LLC with notifications on news.